Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel in vivo and in vitro

• Main Authors: Haifang Chen (Author), Guofeng Li (Author), Ye Liu (Author), Yifan Lang (Author), Wuliang Yang (Author), Wugang Zhang (Author), Xinli Liang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Paclitaxel (PTX) has been the first-line treatment for lung cancer; however, its clinical use is limited due to multidrug resistance (MDR) and adverse effects. Thus, there is an urgent need to explore agents that can enhance the anticancer efficacy of PTX by reducing drug resistance and adverse reac...